Skip to content
Home
Stock Info
NYSE:IGC
Börse Berlín IGS1.BE
Börse frankfurt IGS1.F
Börse Munich IGS1.MU
Börse Stuttgart IGS1.SG
Press Releases
SEC Filing
Company
Our Team
Governance
ESG
Home
Stock Info
NYSE:IGC
Börse Berlín IGS1.BE
Börse frankfurt IGS1.F
Börse Munich IGS1.MU
Börse Stuttgart IGS1.SG
Press Releases
SEC Filing
Company
Our Team
Governance
ESG
Search
NYSE American: IGC
Investor Relations
Committed to transparency and the advancement of next-generation therapies for neurodegenerative diseases through rigorous science and AI-driven innovation.
All Years
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets
January 13, 2025
Read More →
IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer’s Agitation CALMA and Expands Recruitment Strategy
January 8, 2025
Read More →